Amer Haider was the CEO and Co-Founder of Doctella.com, a company that provides cloud-based remote data capture from wearables and medical-grade equipment with digital CarePrograms™ that automates remote care delivery. Doctella was acquired by Masimo (NASDAQ:MASI) in 2018. Prior to Doctella, Amer was part of the executive team at Cavium (NASDAQ: CAVM). Amer has been involved in starting, investing, growing and acquiring companies that have raised over $100 million in venture capital, have been acquired for over $200M and have had a successful public offering creating combined equity value of over $2 billion. He holds 9 issued patents in the areas of security and digital processors. Amer with his wife Munira operates two non-profits related to club-foot and achondroplasia, congenital conditions of their children (www.pehlaqadam.org, www.growingstronger.org). Amer has an MS in Numerical Simulation and an MBA from U of IL at Urbana Champaign.
The vast majority of available genomic data is from participants that are of white, European ancestry, therefore representing a fraction of the world’s population only. Continued disproportionate advances in genome sciences will exacerbate global healthcare disparities in several ways. This session will address how coordinated, multi-sector solutions could address and preempt such disparities to ensure the promise of precision medicines is realized globally.